MedTrace Logo

Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations

NCT05075941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3811

Last updated 2023-04-06

No results posted yet for this study

Summary

The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing.

The secondary objectives are :

* to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers' hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC).
* identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).

Conditions

Interventions

OTHER

Vaccination coverage

proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population

Sponsors & Collaborators

  • Institut de Recherche en Santé Publique, France

    collaborator OTHER

  • Medecins Sans Frontieres, Netherlands

    collaborator OTHER

  • Médecins du Monde

    collaborator OTHER

  • CROIX ROUGE FRANCAISE

    collaborator UNKNOWN

  • OBSERVATOIRE DU SAMU SOCIAL

    collaborator UNKNOWN

  • INTERLOGEMENT 93

    collaborator UNKNOWN

  • Agence Regionale de Sante d'Ile de France

    collaborator OTHER_GOV

  • Epicentre

    lead OTHER

Principal Investigators

  • Elisabeth POULET, MD · Epicentre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2021-12-22
Completion
2021-12-22

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075941 on ClinicalTrials.gov